Anti-tumor TAM subsets (CD74 and CD163-CD206 phagocytic TAMs) exhibited high expression of MHCII and CSF3R, and a 3- and 7-fold increase with ACTM-838 treatment, respectively (Figure 7B, 7C). Here, MRC1 is linked to neoplasm.